This implementation guide was developed by a task force convened by the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland School of Pharmacy with assistance from the US Deprescribing Research Network.
Content as well as resources were solicited from task force members as well as reviewed by outside experts and professional societies over a one week timeframe. Final approval of the guide was provided by general assent of task force members during the final conference call. Scientific literature was reviewed where possible but systematic review of relevant literature was not performed. Recommendations were thus derived mostly from expert opinion.
A note on terminology: In this guide we refer to people receiving care as “residents,” reflecting common terminology in post-acute and long-term care settings. This is intended to be synonymous with the term “patients,” which may be used in other settings. Similarly, we use the term “care partners” to refer to resident allies; this is generally synonymous with the term “caregivers.” We also occasionally reference brand names. This is to aid use by clinicians and does not constitute endorsement of a specific brand-name formulation.
Task Force Members
Name | Title and Affiliations | Disclosures |
---|---|---|
Nicole Brandt, PharmD, MBA, BCGP, BCPP, FASCP (Co-chair) | Executive Director, The Peter Lamy Center on Drug Therapy and Aging Professor, Pharmacy Practice and Science University of Maryland School of Pharmacy |
Dr. Brandt is a member of the American Geriatrics Society Beers Criteria, an Institute for Healthcare Improvement Age-Friendly Health Systems Consultant and receives funding from NIH including for the US Deprescribing Research Network. |
Michael Steinman, MD (Co-chair) | Professor of Medicine (Geriatrics), University of California San Francisco and the San Francisco VA Medical Center Co-principal investigator, US Deprescribing Research Network |
Dr. Steinman is co-chair of the American Geriatrics Society Beers Criteria, co-authors a chapter in UpToDate on deprescribing, received an honorarium from Johns Hopkins University for service on the Society of General Internal Medicine Improving Wisely Collaborative, and receives funding from NIH including for the US Deprescribing Research Network. |
Alice Bonner, PhD, RN, FAAN | Adjunct Faculty, Johns Hopkins University School of Nursing Senior Advisor for Aging, Institute for Healthcare Improvement |
No disclosures |
Cynthia M. Boyd, MD, MPH | Johns Hopkins University School of Medicine Co-principal investigator, US Deprescribing Research Network |
Dr. Boyd co-authors a chapter for UpToDate on multimorbidity. |
Donna Marie Fick, RN, GCNS-BC, PhD, FAAN | Penn State College of Nursing Director, Center of Geriatric Nursing Excellence |
Dr. Fick is a board member for the American Geriatrics Society and member of the AGS Beers Criteria Faculty, Institute for Healthcare Improvement Age-Friendly Health Systems Consultant, Precision Health Economics. |
Jennifer L. Hardesty, PharmD, FASCP | Remedi SeniorCare Chief Clinical Officer & Corporate Compliance Officer |
No disclosures |
Christopher E. Laxton, CAE | Executive Director, AMDA - The Society for Post-Acute and Long-Term Care Medicine | No disclosures |
Lona Mody, MD, MSc | Amanda Sanford Hickey Professor of Internal Medicine, University of Michigan and VA Ann Arbor Healthcare System | Dr. Mody receives funding from NIH, VA, AHRQ, and various non-profit foundations. |
Fatima A. Naqvi, MD, CMD, MMMT, FAAFP | Adjunct Faculty George Washington University and University of Maryland |
No disclosures |
Jonathan Norton, BS | Johns Hopkins University School of Medicine | No disclosures |
Catherine Sarkisian MD, MSHS | David Geffen School of Medicine at University of California Los Angeles, Department of Medicine, Division of Geriatrics Veterans Administration Greater Los Angeles Healthcare System, Geriatric Research Education & Clinical Center |
No disclosures |
Fatima Sheikh, MD, MPH | Chief Medical Officer, FutureCare Health & Management Assistant Professor, Division of Geriatrics, Johns Hopkins School of Medicine |
No disclosures |
Jennifer Tjia, MD, MSc, FAAHPM | Associate Professor of Population and Quantitative Health Sciences University of Massachusetts Medical School |
Dr. Tjia is an expert consultant to CVS Omnicare. |
William Vaughan BSN, RN | Vice President, Education and Clinical Affairs Remedi SeniorCare |
No disclosures |
Chad Worz, PharmD, BCGP | The American Society of Consultant Pharmacists | No disclosures |
Barbara J. Zarowitz, PharmD, FCCP, BCPS, BCGP, FASCP | Senior Advisor, Peter Lamy Center on Drug Therapy and Aging Affiliate Professor, University of Maryland School of Pharmacy |
Dr. Zarowitz received consulting fees from Think Research, Inc. |
External Reviewers and Advisors
We thank the following people who provided suggestions, advice, and review that informed development of this guide, as well as additional comments received from representatives and members of the American Geriatrics Society (AGS), the Society for Post-Acute and Long-Term Care Medicine (AMDA), and the American Society of Consultant Pharmacists (ASCP).
- S. Orion Courtin, MD, MHS
- Barbara Farrell, BScPhm, PharmD, ACPR, FCSHP
- Frank Federico, RPh
- Erin M. Foti, PharmD, BCGP
- Elizabeth Galik, PhD, CRNP, FAAN, FAANP
- Steven M. Handler MD, PhD, CMD
- Daniel Haimowitz, MD
- Peter Hollmann, MD
- Holly Holmes, MD, MS
- Michelle Laughman
- Cathleen Lawrence, RN, MA
- Sunny Linnebur, PharmD
- Nancy Lundebjerg, MPA
- Jay Luxenberg, MD
- Cora Martin, RDN, CSG, LD
- Lynn McPherson, PharmD, MA, MDE, BCPS, CPE
- Amanda Mixon, MD, MSPH
- Joseph Ouslander, MD
- Joshua Pevnick, MD, MSHS
- Barbara Resnick, PhD, RN, CRNP, FAAN, FAANP
- Todd Semla, MS, PharmD, BCGP, FCCP, AGSF
- Belinda Setters, MD
- Sandra Simmons, PhD, MA
- Justin Turner, BPharm, MClinPharm, PhD
- Erin Vigne, MA, RN
- Michi Yukawa, MD, MPH
- Jane Ziegler, DCN, RDN, LDN
Appreciation
We thank Malissa Carroll, MA; Malena Spar, MPH; and Lee Bearson for their outstanding assistance in preparing this guide.